Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser, and may not function properly. More information here...

    Results: 1 to 20 of 128

    1.

    Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.

    Waning B, Kyle M, Diedrichsen E, Soucy L, Hochstadt J, Bärnighausen T, Moon S.

    Global Health. 2010 May 25;6:9.

    PMID:
    20500827
    [PubMed]
    Free PMC Article
    2.

    Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

    Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA.

    PLoS Med. 2007 Nov 13;4(11):e305.

    PMID:
    18001145
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.

    Holmes CB, Coggin W, Jamieson D, Mihm H, Granich R, Savio P, Hope M, Ryan C, Moloney-Kitts M, Goosby EP, Dybul M.

    JAMA. 2010 Jul 21;304(3):313-20.

    PMID:
    20639565
    [PubMed - indexed for MEDLINE]
    4.

    Factors influencing global antiretroviral procurement prices.

    Wirtz VJ, Forsythe S, Valencia-Mendoza A, Bautista-Arredondo S.

    BMC Public Health. 2009 Nov 18;9 Suppl 1:S6.

    PMID:
    19922690
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

    Pinheiro Edos S, Antunes OA, Fortunak JM.

    Antiviral Res. 2008 Sep;79(3):143-65. Epub 2008 Jun 2. Review.

    PMID:
    18571246
    [PubMed - indexed for MEDLINE]
    6.

    Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases.

    Waning B, Kaplan W, King AC, Lawrence DA, Leufkens HG, Fox MP.

    Bull World Health Organ. 2009 Jul;87(7):520-8.

    PMID:
    19649366
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?

    Dionisio D, Gass R, McDermott P, Racalbuto V, Madeo M, Braghieri G, Crowley S, Pinheiro Edos S, Graaff P, Vasan A, Eksaengsri A, Moller H, Khanna AK, Kraisintu K, Juneja S, Nicolaou S, Sengupta A, Esperti F, Messeri D.

    Curr HIV Res. 2007 Mar;5(2):155-87.

    PMID:
    17346132
    [PubMed - indexed for MEDLINE]
    8.

    Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.

    Dhamija P, Bansal D, Medhi B.

    Curr HIV Res. 2009 Jul;7(4):410-7.

    PMID:
    19601776
    [PubMed - indexed for MEDLINE]
    9.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    10.

    Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

    Hoen E, Berger J, Calmy A, Moon S.

    J Int AIDS Soc. 2011 Mar 27;14:15. Review.

    PMID:
    21439089
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.
    12.

    Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

    Meiners C, Sagaon-Teyssier L, Hasenclever L, Moatti JP.

    PLoS One. 2011;6(8):e23478. Epub 2011 Aug 15.

    PMID:
    21858138
    [PubMed - in process]
    Free PMC Article
    13.

    Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) - A Strategic Option for India.

    Satyanarayana K, Srivastava S.

    Open AIDS J. 2010 Jan 19;4:41-53.

    PMID:
    20148091
    [PubMed]
    Free PMC Article
    14.

    [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].

    Kerouedan D.

    Bull Soc Pathol Exot. 2010 May;103(2):119-22. Epub 2010 Apr 7. French.

    PMID:
    20376595
    [PubMed - indexed for MEDLINE]
    15.

    The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund.

    Vasan A, Hoos D, Mukherjee JS, Farmer PE, Rosenfield AG, Perriëns JH.

    Bull World Health Organ. 2006 May;84(5):393-8. Epub 2006 May 17.

    PMID:
    16710550
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Long-term costs and health impact of continued global fund support for antiretroviral therapy.

    Stover J, Korenromp EL, Blakley M, Komatsu R, Viisainen K, Bollinger L, Atun R.

    PLoS One. 2011;6(6):e21048. Epub 2011 Jun 23.

    PMID:
    21731646
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Antiretroviral drug supply challenges in the era of scaling up ART in Malawi.

    Schouten EJ, Jahn A, Ben-Smith A, Makombe SD, Harries AD, Aboagye-Nyame F, Chimbwandira F.

    J Int AIDS Soc. 2011 Jul 6;14 Suppl 1:S4. Review.

    PMID:
    21967844
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    20.

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk